JS
Insider buying
John S. Montalbano bought $95K of AbCellera Biologics Inc. (ABCL) stock
John S. Montalbano, Dir of AbCellera Biologics Inc. (ABCL), bought 20,000 shares of ABCL stock worth $95K, per an SEC Form 4 filed May 18, 2026.
It was an open-market purchase.
The trade happened on May 14, 2026, 4 days before it was made public.
ABCL has moved +187.7% since the trade date, from $4.40 to $12.66 (Sep 21, 2026 close).
- Traded
- May 14, 2026
- Disclosed
- May 18, 2026
- Filing delay
- 4 days
- Price since
- +187.7%
- Role
- Dir
- Source
- SEC Form 4
More ABCL insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.